Skip to content

Clinical trials

Lymphoproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Clear all

202 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20013
20026
20034
20049
200511
20065
200711
200812
20098
201010
20116
20127
20134
20143
20156
20166
20179
20189
20199
20207
20219
20226
202310
20248
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82
Recruiting33
Terminated33
Active, not recruiting23
Unknown status13
Withdrawn9
Not yet recruiting5
No longer available2
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)12
Baylor College of Medicine9
Seagen Inc.7
Cancer Research UK6
National Institute of Allergy and Infectious Diseases (NIAID)6
Amgen Research (Munich) GmbH5
M.D. Anderson Cancer Center5
Mayo Clinic5
UNC Lineberger Comprehensive Cancer Center5
Alliance for Clinical Trials in Oncology4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders202
Lymphoma88
Lymphoma, Non-Hodgkin71
Neoplasms53
Leukemia51
Lymphoma, Large B-Cell, Diffuse49
Multiple Myeloma49
Immunoproliferative Disorders47
Leukemia, Lymphocytic, Chronic, B-Cell47
Lymphatic Diseases47

Trials

Showing 1 to 25 of 202. Each trial links to its page on Pharma Observatory.

102 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.